(Q32135922)

6 July 2017

title

Difference in the homocysteine-lowering effect of folic acid in haemodialysis patients with and without occlusive vascular disease (English)

1 reference

6 July 2017

1 reference

1 reference

1 reference

Descombes E

1

1 reference

6 July 2017

Boulat O

series ordinal

2

1 reference

6 July 2017

Bersier LF

series ordinal

3

1 reference

6 July 2017

Fellay G

series ordinal

4

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

Nephrology Dialysis Transplantation

6 July 2017

published in

1 reference

6 July 2017

volume

16

1 reference

6 July 2017

issue

3

1 reference

6 July 2017

page(s)

585-589

1 reference

Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.

6 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.3.585

Major determinants of hyperhomocysteinemia in peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.3.585

Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.3.585

Water soluble vitamins in chronic hemodialysis patients and need for supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.3.585

Vitamins B6, B12, and folate: association with plasma total homocysteine and risk of coronary atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.3.585

Genetic and nongenetic factors for moderate hyperhomocyst(e)inemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.3.585

Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.3.585

Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.3.585

The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.3.585

Folic acid, pyridoxine, cobalamin, and homocysteine and their relationship to cardiovascular disease in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.3.585

Effect of Usual Doses of Folate Supplementation on Elevated Plasma Homocyst(e)ine in Hemodialysis Patients: No Difference between 1 and 5 mg Daily

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.3.585

Homocysteine and atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.3.585

Hyperhomocyst(e)inaemia in renal failure--what are the implications?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.3.585

Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.3.585

Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: is homocyst(e)ine the missing link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.3.585

Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.3.585

Homocysteine in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.3.585

Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.3.585

Effect of B-group vitamins and antioxidant vitamins on hyperhomocysteinemia: a double-blind, randomized, factorial-design, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F16.3.585

21 January 2018

Identifiers

DOI

10.1093/NDT/16.3.585

1 reference

6 July 2017

1 reference